NCT00631527 - Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

January 31, 2015

Conditions

Prostate Cancer

Interventions

DRUG

Leuprolide

Injections given through a needle in the muscle every 3 months.

DRUG

Goserelin

Subcutaneous injections given once every 3 months.

DRUG

Sunitinib Malate

Starting dose of 12.5 mg by mouth daily for 4 weeks

DRUG

Casodex

Once a day by mouth for 2 weeks.

RADIATION

Radiation Therapy (RT)

Radiation treatment once daily over a period of 8 weeks.

Trial Locations (1)

University of Texas MD Anderson Cancer Center, Houston